Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Given the multifactorial nature of glaucoma-associated ocular surface disease (G-OSD)which involves chronic inflammation, oxidative stress, and tear film instabilitydeveloping novel therapies that target these intersecting pathways is of considerable clinical relevance
D., Angel-Martin, M., Perez-Camino, M
Designed for short-term use, this nonsteroidal anti-inflammatory treatment targets pain and inflammation effectively, whether caused by surgery or other conditions
Cellular and Molecular Biology Letters , 23(1), 40
SOD activity decreases in the late secretory phase while ROS levels increase [100]
Reduces glucagon production (a hormone that raises blood sugar)
US$ 27.73
US$ 26.10
US$ 21.54
US$ 21.91
US$ 21.47
US$ 22.55
US$ 26.08
US$ 29.57
US$ 23.42
US$ 24.54
